Adapalene And Benzoyl Peroxide NDC 46708-662

NDC codes

FDA NDC Directory

Product NDC (as listed)46708-662Labeler and product segments. Claims need a package NDC.

Product NDC at billing width46708-0662Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
46708-662-45	46708066245	1 BOTTLE, PUMP in 1 CARTON (46708-662-45) / 45 g in 1 BOTTLE, PUMPMarketed from May 21, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Adapalene And Benzoyl Peroxide
Generic name (nonproprietary): adapalene and benzoyl peroxide topical
Active ingredients: Adapalene — 3 mg/gBenzoyl peroxide — 25 mg/g
Dosage form: Gel
Route: Topical
Labeler: Alembic Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214185
Marketing start: May 21, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 46708-662_528fc681-2ba1-442f-812f-339f90b0a030SPL ID 528fc681-2ba1-442f-812f-339f90b0a030SPL set ID 2d4e5111-4f9f-42dd-8cf7-56bdc51fbbadRxCUI 1663745UNII 1L4806J2QF, W9WZN9A0GMUPC 0362332662456
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N446708066245 followed by a unit qualifier and the quantity

Package 46708-0662-45. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 27, 2025.

Indications (excerpt from the label)

Adapalene and benzoyl peroxide topical gel is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. Adapalene and benzoyl peroxide topical gel, is a combination of adapalene, a retinoid, and benzoyl peroxide and is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214185

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214185
Product	Strength	Form · route	Labeler	Product NDC
Adapalene And Benzoyl Peroxideadapalene and benzoyl peroxide topical	Adapalene 3 mg/g; Benzoyl peroxide 25 mg/g	GelTopical	Alembic Pharmaceuticals Inc.	62332-662